Biogen (NASDAQ:BIIB) inks a strategic collaboration with privately held C4 Therapeutics aimed at investigating the latter's novel protein degradation ... read more
Biogen teams up with C4 Therapeutics in neurology
Biogen teams up with C4 Therapeutics in neurology